Placebo (PCB)

DRUG2 trials

Sponsors

New York State Psychiatric Institute

Conditions

Opioid-Related DisordersOpioid-related Disorders

Phase 2

Phase IIa Study of AV411, a Glial Activation Inhibitor, for Opioid Withdrawal

CompletedNCT00723177

New York State Psychiatric InstituteOpioid-Related Disorders

Start: 2008-10-31End: 2012-06-30Updated: 2016-12-05

Phase 3

Abuse Liability of Suboxone Versus Subutex

CompletedNCT00710385

New York State Psychiatric InstituteOpioid-related Disorders

Start: 2007-09-30End: 2008-08-31Updated: 2016-12-05